Innovating for the Future: The Race to Develop Antibiotic Resistance Treatments| Thermo Fisher Scientific, Merck KgaA, Bio-Rad Laboratories, Takara Bio, Inc, QIAGEN N.V., Pall Corporation

Antibiotic resistance is a growing public health concern, as bacteria develop resistance to commonly used antibiotics, making infections more difficult to treat and potentially leading to increased morbidity and mortality. The antibiotic resistance market includes a range of pharmaceutical and diagnostic products, as well as research and development efforts aimed at developing new antibiotics and combating resistance.

Worldwide revenue from the antibiotic resistance market stands at US$ 10.1 Billion in 2022, with the global market estimated to surge ahead at a CAGR value of 5.3% to reach a valuation of US$ 17.8 Billion by the end of 2033.

Leading Players are:

  • Thermo Fisher Scientific, Inc
  • Merck KgaA
  • Bio-Rad Laboratories, Inc.
  • Takara Bio, Inc.
  • Pall Corporation
  • Eppendorf Corporate
  • Tarsons Products PVT. LTD.
  • Applied Biological Materials Inc.

Get a Free PDF Sample of this Report Here:

One of the key drivers of the market is the increasing prevalence of antibiotic-resistant infections. The World Health Organization has identified antibiotic resistance as one of the greatest threats to global health, and estimates that at least 700,000 people die each year as a result of drug-resistant infections. As bacteria continue to evolve and develop resistance to existing antibiotics, there is an urgent need for new treatment options.

Another factor driving growth in the antibiotic resistance market is the increasing investment in research and development. Governments and private companies around the world are investing heavily in efforts to develop new antibiotics and combat resistance, including initiatives such as the Antibiotic Resistance Action Center at George Washington University and the UK government’s 20-year strategy to tackle antimicrobial resistance.

However, the antibiotic resistance market is not without its challenges. One of the main obstacles is the high cost of research and development for new antibiotics. Developing a new antibiotic can take years and cost hundreds of millions of dollars, and many pharmaceutical companies are hesitant to invest in a market that may not be profitable.

You Can Purchase this Report as per Your Interest Click Here:

Overall, the antibiotic resistance market is expected to continue to grow in the coming years, driven by a combination of factors such as increasing prevalence of resistance, growing investment in research and development, and regulatory support for new therapies. However, companies in the industry will need to navigate a range of challenges, including the need for continued investment in research and development, the regulatory hurdles associated with bringing new antibiotics to market, and the need for increased awareness and action to combat antibiotic resistance.

Check out more Premium studies published by Persistence Market Research

Life Sciences Aggregate-Spending Market
Europe Cryochambers Market
Clostridium Difficile Infection Treatment Market
Airway Clearance System Market
Effervescent Products Market

About Persistence Market Research: 

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.


Persistence Market Research

Address – 305 Broadway, 7th Floor, New York City,

NY 10007 United States

U.S. Ph. – +1-646-568-7751

USA-Canada Toll-free – +1 800-961-0353

Sales –

Antibiotic Resistance Market Global Research and Clinical Survey Report 2020

The Antibiotic Resistance Market report is a collection of pragmatic information, quantitative and qualitative estimation by industry experts, the contribution from industry connoisseurs and industry accomplices across the value chain. Furthermore, the report also provides the qualitative results of diverse market factors on its geographies and segments.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Get sample copy of this report before purchase at:

The prominent players in the global Antibiotic Resistance market are:

Allergan, AmpliPhi Biosciences, BioVersys GmbH, Macrolide Pharmaceuticals, Melinta Therapeutics, Merck, Nabriva Therapeutics, Nemesis Bioscience, Phage Technologies S.A, Tetraphase Pharmaceuticals, The Medicines Company, TPfizer, Westway Health.

Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality.

Antibiotic Resistance Global Market Report from Market Insights Reports covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market. The market characteristics section of the report defines and explains the market. The market size section gives the market revenues, covering both the historic growth of the market and forecasting the future. Drivers and restraints look at the external factors influencing the growth of the market. Market segmentations break down the key sub sectors which make up the market.

Market segment by Types

By Disease – Urinary Tract Infection, Intra-Abdominal Infections, Blood Stream Infections

Clostridium Difficile Infections, Acute Bacterial Skin and Skin Structure Infections, Bacterial Pneumonia

By Pathogen – Carbapenem-Resistant, Carbapenem-Resistant, Methicillin-Resistant, Carbapenem-Resistant, Penicillin-Non-Susceptible, Cephalosporin-Resistant, Tetracycline-Resistant, Vancomycin-Resistant, Ampicillin-Resistant

Market segment by Application

Combination therapies

Get full access to this report at:

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last five years are identified. The trends and strategies section highlights the likely future developments in the market and suggests approaches.

Following are major Table of Content of Antibiotic Resistance Industry:

  • Antibiotic Resistance Market Sales Overview.
  • Antibiotic Resistance Market Sales Competition by Manufacturers.
  • Antibiotic Resistance Market Sales Analysis by Region.
  • Antibiotic Resistance Market Sales Analysis by Type.
  • Antibiotic Resistance Market Analysis by Application.
  • Antibiotic Resistance Market -Manufacturers Analysis.

The research includes historic data from 2015 to 2019 and forecasts until 2026 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact US:

Irfan Tamboli (Head of Sales)

Market Insights Reports

Phone: + 1704 266 3234 | Mob: +91-750-707-8687 |